Hasan Hüseyin Kozak

Prof. Dr. Hasan Hüseyin Kozak

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Clinical Neuropharmacology
Verified
Journal Article
Closed access
AUAli Ulvi Uca
Ali Ulvi Uca
FUFaruk Uğuz
Faruk Uğuz
HKHasan Hüseyin Kozak
Hasan Hüseyin Kozak
HGHaluk Gümüş
Haluk Gümüş
FAFadime Aksoy
Fadime Aksoy
HKHatice Güncü Kurt
Hatice Güncü Kurt
The relationship between sleep bruxism and antidepressant drugs in patients remains unclear. In this study, we aimed to investigate the incidence rate of antidepressant-related bruxism and to examine whether antidepressant use is associated with this adverse effect in the patients. The study sample was gathered from 2 hospitals. A total of 807 patients who met the inclusion criteria were included in the study. The sample was divided into 2 groups: the antidepressant group (n = 506) and the control group (n = 301). Sleep bruxism was established with reports from the study participants on the basis of the International Classification of Sleep Disorders: Diagnosis and Coding Manual Second Edition. The prevalence of bruxism was significantly higher in the antidepressant group (24.3%) than in the control group (15.3%). The incidence of antidepressant-induced bruxism was 14.0%. The antidepressants most associated with bruxism were paroxetine, venlafaxine, and duloxetine. The patients experiencing antidepressant-induced bruxism had higher age compared with those who did not experience this adverse effect. The results of the present study suggest that bruxism is frequently observed in women taking antidepressants and that it seems to be associated with antidepressant use at least in some patients.

19 March 2015 in Journal of Neuroimaging
Verified
Journal Article
Closed access
PDF file
MTMehmet A. Topcuoglu
Mehmet A. Topcuoglu
EAE. Murat Arsava
E. Murat Arsava
DBD. Funda Bas
D. Funda Bas
HKHasan Hüseyin Kozak
Hasan Hüseyin Kozak

1 January 2017 in Neurologia i Neurochirurgia Polska
Verified
Journal Article
Closed access
HKHasan Hüseyin Kozak
Hasan Hüseyin Kozak
FUFaruk Uğuz
Faruk Uğuz
IKİbRahim Kılınç
İbRahim Kılınç
AUAli Ulvi Uca
Ali Ulvi Uca
OTOsman Serhat Tokgöz
Osman Serhat Tokgöz
NÖNejla Özer
Nejla Özer
Stroke patients with development of delirium have unfavorable outcomes, higher mortality, longer hospitalizations, and a greater degree of dependence after discharge. Studies suggest that delirium is associated with abnormal immunological responses and a resultant increase in inflammatory markers. Our aim was to determine whether there is an entity relationship between delirium, inflammation and acute ischemic stroke (AIS). Sixty AIS patients admitted to the hospital were consecutively recruited. Delirium was diagnosed with the clinical assessment according to the Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria. Enzyme-linked immunosorbent assay (ELISA) was used to measure serum levels of Interleukin-1 beta (IL-1 beta), Interleukin 18 (IL-18), Tumor Necrosis Factor-alpha (TNF-alpha), Brain-Derived Neurotrophic Factor (BDNF), and Neuron Specific Enolase (NSE) at admission. Eleven (18.3%) of 60 patients were diagnosed with delirium, and the majority (n=8, 72.7%) was the hypoactive type. Delirious and non-delirious patients had similar demographic and clinical features. Delirious patients had significantly higher lengths of hospital stay, National Institutes of Health Stroke Scale (NIHSS) at admission and discharge compared to non-delirious patients. In addition, there was no significant statistical difference between delirious and non-delirious patients with AIS in respect of levels of TNF-alpha, IL-1 beta, IL-18, BDNF and NSE. This study suggests that delirium is not scarce in patients with AIS admitted to the non-intensive stroke unit, and that delirium developing after AIS seems not to be associated with serum TNF-alpha, IL-1 beta, IL-18, BDNF and NSE but is associated with length of hospital stay and stroke severity.

17 November 2016 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
HKHasan Hüseyin Kozak
Hasan Hüseyin Kozak
MBMurat Boysan
Murat Boysan
AUAli Ulvi Uca
Ali Ulvi Uca
AAAdem Aydın
Adem Aydın
IKİbRahim Kılınç
İbRahim Kılınç
NÖNejla Özer
Nejla Özer

3 February 2023 in Clinical Nutrition
Verified
Journal Article
Closed access
LGLevent Gungor
Levent Gungor
EAEthem Murat Arsava
Ethem Murat Arsava
AGAyse Guler
Ayse Guler
CICanan Togay Isikay
Canan Togay Isikay
ÖAözlem Aykaç
özlem Aykaç
CUCaglar Uzun
Caglar Uzun

11 November 2016 in Archives of Neuropsychiatry
Verified
Journal Article
Closed access
HKHasan Hüseyin Kozak
Hasan Hüseyin Kozak
MDMehmet Akif Dundar
Mehmet Akif Dundar
AUAli Ulvi Uca
Ali Ulvi Uca
FUFaruk Uguz
Faruk Uguz
KTKeziban Turgut
Keziban Turgut
SASuhayb Kuria Aziz
Suhayb Kuria Aziz
Introduction: This study presents the current prevalence of anxiety, mood, and personality disorders as well as factors associated with the existence of psychiatric disorders in patients with benign paroxysmal positional vertigo (BPPV). Methods: The study sample comprised 46 patients with BPPV and 74 control subjects. Anxiety and mood disorders were ascertained via the Structured Clinical Interview for the Diagnostic and Statistical Manual (DSM) of Mental Disorders, Fourth Edition/Clinical Version. Personality disorders were diagnosed via the Structured Clinical Interview for DSM, Revised Third Edition, Personality Disorders. Results: Of the 46 patients, 18 (391%) had at least one mood or anxiety disorder and 13 (283%) had at least one personality disorder. The most common Axis I and Axis II disorders in the patient group were major depression in 8 (17.4%) and obsessive-compulsive personality disorder in 10 (21.7%) patients, respectively. It was found that major depression (p=0.021), generalized anxiety disorder (p=0.026) and obsessive compulsive personality disorder (p=0.001) were more prevalent in the BPPV group compared with the control group. Conclusion: Results suggest that psychiatric disturbances should be carefully checked in patients with BPPV due to the relatively high rate of comorbidity.